Stocks
Amicus Therapeutics (FOLD) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -332.3 | -243.0 | -202.9 | -199.6 | -92.1 | -9.20 | ||
| Changes by years, y/y, % | +5% | -27% | -17% | -2% | -54% | -21.9% | |||
Amicus Therapeutics. EBITDA US GAAP, bln rub
Amicus Therapeutics. EBITDA US GAAP, changes, %
Amicus Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Amicus Therapeutics (FOLD) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -9.49 | -16.7 | -29.0 | 14.8 | 21.6 | -9.20 | |
| Changes by years, y/y, % | -47% | -70% | -27% | -161% | -328% | |||
| Changes by quarters, q/q, % | -61% | +75% | +74% | -151% | +46% | |||
